Showing results (11-20 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|June 23, 2021
Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ-951), an Oral Erythropoiesis-Stimulating Agent, in Healthy AdultsSudhakar M Pai, Hiroyuki Yamada, Robert B Kleiman, et al.
Clinical Pharmacology in Drug Development|January 16, 2023
Pharmacokinetics and Comparative Bioavailability of Test or Reference Capecitabine and Discrepant Pharmacokinetics Among Various Tumors in Chinese Solid Cancer PatientsXiaoyu Li, Dongyang Cui, Jianping Xiong, et al.
Clinical Pharmacology in Drug Development|December 30, 2022
Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and PharmacodynamicsYoichiro Ogama, Yuji Kumagai, Norio Komatsu, et al.
Clinical Pharmacology in Drug Development|January 9, 2023
Relative Bioavailability and Food Effect of Asciminib Pediatric Mini-tablet Formulation Compared to the Reference Tablet Formulation in Healthy Adult ParticipantsMatthias Hoch, Lidiya Bebrevska, Namrata Singh, et al.
Clinical Pharmacology in Drug Development|January 10, 2023
Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese SubjectsYuan Li, Haitao Yu, Bing Xu, et al.
Clinical Pharmacology in Drug Development|June 17, 2022
The Safety, Toleration, and Pharmacokinetics of Two Intravenous Voriconazole Formulations in Healthy Chinese Volunteers After Increasing Dose AdministrationsGang Chen, Zejuan Wang, Xiaona Liu, et al.
Clinical Pharmacology in Drug Development|May 5, 2022
Clinical Formulation Bridging of Gefapixant, a P2X3-Receptor Antagonist, for the Treatment of Chronic CoughPranav Gupta, Azher Hussain, Anthony P Ford, et al.
Clinical Pharmacology in Drug Development|October 12, 2021
Bioequivalence and Food Effect Assessment of 2 Rivaroxaban Formulations in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, and 4-Period Crossover StudyYe Tao, Xin Jiang, Ping Shi, et al.
Clinical Pharmacology in Drug Development|March 25, 2021
Randomized, Open-Label, Single-Dose, Parallel-Group Pharmacokinetic Study of PF-06410293 (adalimumab-afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syringe or a Prefilled Pen in Healthy SubjectsDonna S Cox, Daniel F Alvarez, Amy E Bock, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Comparative Sirolimus Pharmacokinetics After Single-Dose Administration of Two Prototype 0.5-mg Tablets in Healthy VolunteersJoan M Korth-Bradley, Indranil Bhattacharya, Kyle Matschke, et al.
Pageof 135